When Silence Speaks: How BRCA1 Hypermethylation Fuels Sporadic Breast Cancers
Targeted promoter hypermethylation of BRCA1 uncovers how epigenetic silencing integrates transcriptional repression, hormonal adaptation, and immune modulation to reshape tumor identity.